Congrès Scientifique: Innovation contre le Cancer
Le monde médical, scientifique et pharmaceutique se bat, chaque jour, au travers de programmes et centres de recherches nationaux, internationaux, académiques et industriels pour faire avancer l’innovation dans le traitement du cancer.
Our webinar is online: Mass spectrometry toolkit for the characterisation of protein glycosylation
Access this 45 minute webinar to learn how state-of-the-art LC/MS technologies can be implemented for the efficient study of therapeutic protein glycosylation using analyses optimised for each level of information you need.
Our webinar is online: mAbs characterisation by Surface Plasmon Resonance
Access this 45 minute webinar to learn how Surface Plasmon Resonance can be implemented in a GMP regulated environment for the comprehensive study of monoclonal antibodies and other Biologics.
2D-LC–MS for the Analysis of Monoclonal Antibodies and Antibody–Drug Conjugates in a Regulated Environment
Herein, we present the development and use for marketed monoclonal antibodies (mAbs) and antibody–drug conjugates (ADCs) of two-dimensional (2D) liquid chromatography (LC)–MS via an on-line desalting step.
Mass spectrometry as a powerful tool for the characterisation of monoclonal antibodies in the context of comparability studies
In this article, the use of mass spectrometry as a powerful tool for comparability studies is presented, with applications of the methods to a commercial product: Humira® (Adalimumab).
State-of-the-Art MS Methods for Structural Assessment of mAbs and ADCs: From the Research Lab to Routine Characterization
HPLC 2016 conference (San Francisco, from 19-24 June 2016)
by Alain Beck and Arnaud Delobel
Elemental impurities: The pharmaceutical industry is up against the wall!
Press release - Communiqué de presse
Un partenaire indispensable pour votre crédit d'impôts en R&D!
Bonne nouvelle pour nos partenaires français!
Elemental impurities According to ICH Q3D
ICH Q3D Step4 will have to be applied very soon: June 2016 for new Drug Products and 1st January 2018 for all existing DP, making it mandatory for all manufacturers to carry out a risk assessment to control elemental impurities in their DP.
Watch the conference given by Philippe De Raeve, Scientific Director at Quality Assistance